- Home
- CYH vs HQL Comparison
CYH vs HQL Comparison
Compare CYH & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- HQL
- Stock Information
- Founded
- CYH 1985
- HQL 1992
- Country
- CYH United States
- HQL United States
- Employees
- CYH N/A
- HQL N/A
- Industry
- CYH Hospital/Nursing Management
- HQL Investment Managers
- Sector
- CYH Health Care
- HQL Finance
- Exchange
- CYH Nasdaq
- HQL Nasdaq
- Market Cap
- CYH 362.0M
- HQL 368.7M
- IPO Year
- CYH 1991
- HQL N/A
- Fundamental
- Price
- CYH $3.50
- HQL $11.98
- Analyst Decision
- CYH Hold
- HQL
- Analyst Count
- CYH 8
- HQL 0
- Target Price
- CYH $4.02
- HQL N/A
- AVG Volume (30 Days)
- CYH 3.4M
- HQL 120.9K
- Earning Date
- CYH 04-23-2025
- HQL 01-01-0001
- Dividend Yield
- CYH N/A
- HQL 11.56%
- EPS Growth
- CYH N/A
- HQL N/A
- EPS
- CYH N/A
- HQL 0.79
- Revenue
- CYH $12,653,000,000.00
- HQL N/A
- Revenue This Year
- CYH N/A
- HQL N/A
- Revenue Next Year
- CYH $4.15
- HQL N/A
- P/E Ratio
- CYH N/A
- HQL $17.08
- Revenue Growth
- CYH 1.05
- HQL N/A
- 52 Week Low
- CYH $2.24
- HQL $11.34
- 52 Week High
- CYH $6.29
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- CYH 74.92
- HQL 42.81
- Support Level
- CYH $2.77
- HQL $11.88
- Resistance Level
- CYH $2.94
- HQL $13.09
- Average True Range (ATR)
- CYH 0.21
- HQL 0.28
- MACD
- CYH 0.11
- HQL -0.01
- Stochastic Oscillator
- CYH 92.06
- HQL 9.76
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.